Strategies for Curative Fluorescence-Guided Surgery of Cancer

Dr. Robert Hoffman graduated from Harvard University in 1971 with a PhD in Biology - Professor James D. Watson was a member on his thesis committee. He did post-doctoral training at Harvard Medical School and Massachusetts General Hospital. Dr. Hoffman also trained at the Institute of Bioorganic Chemistry in Moscow, where he was a U.S. National Academy of Sciences/Soviet Academy of Science Exchange Scholar. It was at the Institute of Bioorganic Chemistry that he produced the first-DNA-liposomes, a work leading to the opening of the field of gene therapy. Dr. Hoffman have been a faculty member at the UCSD School of Medicine since 1979 where he is currently a Professor of Surgery. He founded the biotechnology company, AntiCancer, Inc., in 1984 and has been the President and CEO since then. He has published almost 800 scientific papers, which have been cited more than 30,000 times over a 51-year scientific career. Dr. Hoffman has received the Sun Lee Award of 2016 from the International Society for Experimental Microsurgery for “outstanding, pioneering and great contributions to the progress of experimental microsurgery”. He is a pioneer in the development of fluorescence-guided surgery.

• 1. Cancer surgery: the major problems and impediments for cure2. FGS: the major principles3. Principles of antibody labelling of tumors for FGS4. Principles of labelling of tumors with genetic reporters for FGS5. Principles of curative FGS of cancer6. Principles of curative FGS of pancreatic cancer7. Principles of curative FGS of liver metastasis8. Principles of curative FGS of soft-tissue sarcoma9. Principles of curative FGS of glioma10. Principles of curative FGS of melanoma11. Principles of curative FGS of triple-negative breast cancer12. Principles of curative FGS of lung cancer13. Color-coded labeling of cancer and stroma for curative FGS14. Future of curative FGS15. Instrumentation for FGS